Ubs Group Ag Assertio Holdings, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 17,110 shares of ASRT stock, worth $15,912. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,110

Previous 59,866 71.42%

Holding current value

$15,912

Previous $74,000 72.97%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.07 - $1.75 $45,748 - $74,823	-42,756 Reduced 71.42%	17,110 $20,000
Q2 2024 Aug 13, 2024	SELL	$0.75 - $1.31 $32,505 - $56,776	-43,341 Reduced 41.99%	59,866 $74,000
Q1 2024 May 13, 2024	SELL	$0.79 - $1.14 $75,979 - $109,640	-96,176 Reduced 48.24%	103,207 $99,000
Q4 2023 Feb 09, 2024	SELL	$1.02 - $2.57 $44,951 - $113,259	-44,070 Reduced 18.1%	199,383 $213,000
Q3 2023 Nov 09, 2023	BUY	$2.52 - $5.69 $95,371 - $215,343	37,846 Added 18.41%	243,453 $623,000
Q2 2023 Aug 11, 2023	BUY	$5.0 - $7.66 $461,380 - $706,834	92,276 Added 81.42%	205,607 $1.11 Million
Q1 2023 May 12, 2023	BUY	$3.54 - $6.66 $341,422 - $642,337	96,447 Added 571.23%	113,331 $721,000
Q4 2022 Feb 08, 2023	BUY	$2.11 - $4.3 $18,897 - $38,510	8,956 Added 112.97%	16,884 $72,000
Q3 2022 Nov 10, 2022	BUY	$2.13 - $4.0 $7,005 - $13,156	3,289 Added 70.9%	7,928 $18,000
Q2 2022 Aug 10, 2022	BUY	$1.88 - $3.42 $7,497 - $13,638	3,988 Added 612.6%	4,639 $13,000
Q1 2022 May 16, 2022	BUY	$2.06 - $3.0 $49 - $72	24 Added 3.83%	651 $1,000
Q4 2021 Feb 14, 2022	SELL	$0.86 - $2.3 $1,935 - $5,175	-2,250 Reduced 78.21%	627 $1,000
Q3 2021 Nov 15, 2021	SELL	$0.89 - $1.55 $17,200 - $29,955	-19,326 Reduced 87.04%	2,877 $3,000
Q2 2021 Aug 13, 2021	BUY	$1.48 - $2.88 $32,860 - $63,944	22,203 New	22,203 $34,000

Others Institutions Holding ASRT

# of Institutions

Shares Held

31M

Call Options Held

957K

Put Options Held

38.5K

View Full List

About Assertio Holdings, Inc.

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $44.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

More about ASRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account